Pharmacokinetics and renal clearance of oxytetracycline after intravenous and intramuscular administration to dairy cows. 1985

J F Nouws, and T B Vree, and E Termond, and J Lohuis, and P van Lith, and G J Binkhorst, and H J Breukink

Following intravenous administration of an oxytetracycline-HC1 and an oxytetracycline-dihydrate formulation to dairy cows, no statistical difference could be found between the pharmacokinetic parameters, derived from the three-compartment model, of these preparations. Urinary recovery was continued for a period of 72 h following intravenous or intramuscular OTC administration. The recovery of OTC in the urine in the 72-h period was in the range of 73% to 96% of the available dose administered. The renal OTC clearance, the renal creatinine clearance, the urinary flow, and the interrelationships of these were determined on the basis of urine and plasma data. The mean OTC renal clearance ranged from 482 to 1050 ml/min and the creatinine clearance from 651 to 1304 ml/min. The OTC and creatinine clearances were significantly correlated to the urine flow up to 30 ml/min. The total body clearance and renal clearance values were of the same order of magnitude, and along with the urine recovery data they provided evidence of predominantly renal route of OTC elimination in dairy cows. The renal OTC elimination is the net result of mainly glomerular filtration, partly tubular secretion, minus reabsorption in the urogenital tract.

UI MeSH Term Description Entries
D007273 Injections, Intramuscular Forceful administration into a muscle of liquid medication, nutrient, or other fluid through a hollow needle piercing the muscle and any tissue covering it. Intramuscular Injections,Injection, Intramuscular,Intramuscular Injection
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D007700 Kinetics The rate dynamics in chemical or physical systems.
D010118 Oxytetracycline A TETRACYCLINE analog isolated from the actinomycete STREPTOMYCES RIMOSUS and used in a wide variety of clinical conditions. Hydroxytetracycline,Bisolvomycin,Geomycin,Oxyterracin,Oxyterracine,Oxytetracid,Oxytetracycline Anhydrous,Oxytetracycline Calcium,Oxytetracycline Dihydrate,Oxytetracycline Hydrochloride,Oxytetracycline Monohydrochloride,Oxytetracycline Sulfate (2:1),Oxytetracycline, (4a beta,5 beta,5a beta,12a beta)-Isomer,Oxytetracycline, (5 beta)-Isomer,Oxytetracycline, Anhydrous,Oxytetracycline, Calcium (1:1) Salt,Oxytetracycline, Disodium Salt, Dihydrate,Oxytetracycline, Sodium Salt,Terramycin
D002417 Cattle Domesticated bovine animals of the genus Bos, usually kept on a farm or ranch and used for the production of meat or dairy products or for heavy labor. Beef Cow,Bos grunniens,Bos indicus,Bos indicus Cattle,Bos taurus,Cow,Cow, Domestic,Dairy Cow,Holstein Cow,Indicine Cattle,Taurine Cattle,Taurus Cattle,Yak,Zebu,Beef Cows,Bos indicus Cattles,Cattle, Bos indicus,Cattle, Indicine,Cattle, Taurine,Cattle, Taurus,Cattles, Bos indicus,Cattles, Indicine,Cattles, Taurine,Cattles, Taurus,Cow, Beef,Cow, Dairy,Cow, Holstein,Cows,Dairy Cows,Domestic Cow,Domestic Cows,Indicine Cattles,Taurine Cattles,Taurus Cattles,Yaks,Zebus
D003404 Creatinine Creatinine Sulfate Salt,Krebiozen,Salt, Creatinine Sulfate,Sulfate Salt, Creatinine
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

J F Nouws, and T B Vree, and E Termond, and J Lohuis, and P van Lith, and G J Binkhorst, and H J Breukink
January 1993, Veterinary research communications,
J F Nouws, and T B Vree, and E Termond, and J Lohuis, and P van Lith, and G J Binkhorst, and H J Breukink
December 1995, Journal of veterinary pharmacology and therapeutics,
J F Nouws, and T B Vree, and E Termond, and J Lohuis, and P van Lith, and G J Binkhorst, and H J Breukink
March 1992, Journal of veterinary pharmacology and therapeutics,
J F Nouws, and T B Vree, and E Termond, and J Lohuis, and P van Lith, and G J Binkhorst, and H J Breukink
January 2003, Acta veterinaria Scandinavica,
J F Nouws, and T B Vree, and E Termond, and J Lohuis, and P van Lith, and G J Binkhorst, and H J Breukink
July 2020, Antibiotics (Basel, Switzerland),
J F Nouws, and T B Vree, and E Termond, and J Lohuis, and P van Lith, and G J Binkhorst, and H J Breukink
March 2020, Journal of veterinary pharmacology and therapeutics,
J F Nouws, and T B Vree, and E Termond, and J Lohuis, and P van Lith, and G J Binkhorst, and H J Breukink
June 2012, Journal of veterinary pharmacology and therapeutics,
J F Nouws, and T B Vree, and E Termond, and J Lohuis, and P van Lith, and G J Binkhorst, and H J Breukink
March 1992, Journal of veterinary pharmacology and therapeutics,
J F Nouws, and T B Vree, and E Termond, and J Lohuis, and P van Lith, and G J Binkhorst, and H J Breukink
January 1973, Journal of the American Veterinary Medical Association,
J F Nouws, and T B Vree, and E Termond, and J Lohuis, and P van Lith, and G J Binkhorst, and H J Breukink
December 1985, Casopis lekaru ceskych,
Copied contents to your clipboard!